The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group
Preoperative breast biopsy might cause disaggregation of tumour cells and tumour cell spread. The purpose of this study was to investigate the impact of preoperative biopsy on the rate of metastases to the sentinel lymph node (SLN) of patients with primary breast cancer. We report the results of 250...
Gespeichert in:
| Veröffentlicht in: | British journal of cancer 2004-11, Vol.91 (10), p.1782-1786 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1786 |
|---|---|
| container_issue | 10 |
| container_start_page | 1782 |
| container_title | British journal of cancer |
| container_volume | 91 |
| creator | Peters-Engl, C Konstantiniuk, P Tausch, C Haid, A Hoffmann, B Jagoutz-Herzlinger, M Kugler, F Redtenbacher, S Roka, S Schrenk, P Steinmassl, D |
| description | Preoperative breast biopsy might cause disaggregation of tumour cells and tumour cell spread. The purpose of this study was to investigate the impact of preoperative biopsy on the rate of metastases to the sentinel lymph node (SLN) of patients with primary breast cancer. We report the results of 2502 patients with primary breast cancer, who were operated, and a sentinel node biopsy was performed. The association of preoperative biopsy with the risk of SLN metastases was examined by regression analyses and tested for possible confounding well-known factors for axillary node metastases. In all, 1890 patients were available for final analyses; 1048 (55.4%) patients had a preoperative diagnosis performed by fine-needle aspiration or core biopsy; 641 (33.9%) patients had a positive SLN when conventional H&E and IHC staining was performed. Patients with preoperative breast biopsy showed a 1.37 times (95% CI, 1.13–1.66) increased risk of SLN metastases on univariate analysis, but this result was not persistent when analysis was adjusted for other relevant factors for axillary node metastases, OR 1.09 (95% CI, 0.85–1.40). In addition, subgroup analyses of the risk for occult micro metastases to the SLN (detected by IHC only) on H&E-negative cases also showed no increased risk associated with preoperative biopsy, OR 1.07 (95% CI, 0.69–1.65). The conclusion, based on the present data, is that preoperative breast biopsy does not cause artificial tumour cell spread to the SLN, with possible negative impact on the prognosis of breast cancer. |
| doi_str_mv | 10.1038/sj.bjc.6602205 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2410051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67064344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-70db895874c6ff5f5db07c7f94361b6cc47a993b264a8af20dd259b8f873dbb3</originalsourceid><addsrcrecordid>eNp1kc-P1CAUx4nRuOPq1aMhHrx1llIoxYPJZuOvZBMvcydA6Qy1LZVHN5k_x_9UZqdx1MQTgfd5n_fCF6HXJdmWpGpuoN-a3m7rmlBK-BO0KXlFi7Kh4inaEEJEQSQlV-gFQJ-vkjTiOboqOROi4XKDfu4ODvtx1jbh0OE5ujC7qJN_cNhEpyFh48MMRxwmnDIbPXw_keCm5Cc34OE4zgc8hdbh0aXcoMHBe6wnPRzBw4mlnFBsT--4i2F89NwukKLX00X0qFiHQVraI97HsMwv0bNOD-Berec12n36uLv7Utx_-_z17va-sIzzVAjSmkbyRjBbdx3veGuIsKKTrKpLU1vLhJayMrRmutEdJW1LuTRN14iqNaa6Rh_O2nkxo2tt3irqQc3RjzoeVdBe_V2Z_EHtw4OirCSEl1nwbhXE8GNxkNTowbph0JMLC6hakJpVjGXw7T9gH5aYvwsUpVIKxkSToe0ZsjEARNf93qQk6pS8gl7l5NWafG548-f-F3yNOgM3ZwByadq7eBn7H-UvXV6-ZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229974478</pqid></control><display><type>article</type><title>The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group</title><source>MEDLINE</source><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Peters-Engl, C ; Konstantiniuk, P ; Tausch, C ; Haid, A ; Hoffmann, B ; Jagoutz-Herzlinger, M ; Kugler, F ; Redtenbacher, S ; Roka, S ; Schrenk, P ; Steinmassl, D</creator><creatorcontrib>Peters-Engl, C ; Konstantiniuk, P ; Tausch, C ; Haid, A ; Hoffmann, B ; Jagoutz-Herzlinger, M ; Kugler, F ; Redtenbacher, S ; Roka, S ; Schrenk, P ; Steinmassl, D ; Austrian Sentinel Node Biopsy Study Group</creatorcontrib><description>Preoperative breast biopsy might cause disaggregation of tumour cells and tumour cell spread. The purpose of this study was to investigate the impact of preoperative biopsy on the rate of metastases to the sentinel lymph node (SLN) of patients with primary breast cancer. We report the results of 2502 patients with primary breast cancer, who were operated, and a sentinel node biopsy was performed. The association of preoperative biopsy with the risk of SLN metastases was examined by regression analyses and tested for possible confounding well-known factors for axillary node metastases. In all, 1890 patients were available for final analyses; 1048 (55.4%) patients had a preoperative diagnosis performed by fine-needle aspiration or core biopsy; 641 (33.9%) patients had a positive SLN when conventional H&E and IHC staining was performed. Patients with preoperative breast biopsy showed a 1.37 times (95% CI, 1.13–1.66) increased risk of SLN metastases on univariate analysis, but this result was not persistent when analysis was adjusted for other relevant factors for axillary node metastases, OR 1.09 (95% CI, 0.85–1.40). In addition, subgroup analyses of the risk for occult micro metastases to the SLN (detected by IHC only) on H&E-negative cases also showed no increased risk associated with preoperative biopsy, OR 1.07 (95% CI, 0.69–1.65). The conclusion, based on the present data, is that preoperative breast biopsy does not cause artificial tumour cell spread to the SLN, with possible negative impact on the prognosis of breast cancer.</description><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6602205</identifier><identifier>PMID: 15477859</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Aged ; Austria ; Axilla ; Biomedical and Life Sciences ; Biomedicine ; Biopsy ; Biopsy, Needle ; Breast Neoplasms - diagnosis ; Breast Neoplasms - pathology ; Cancer Research ; Clinical ; Disease Progression ; Drug Resistance ; Epidemiology ; Female ; Humans ; Lymphatic Metastasis ; Middle Aged ; Molecular Medicine ; Oncology ; Preoperative Care ; Regression Analysis ; Risk ; Sentinel Lymph Node Biopsy</subject><ispartof>British journal of cancer, 2004-11, Vol.91 (10), p.1782-1786</ispartof><rights>The Author(s) 2004</rights><rights>Copyright Nature Publishing Group Nov 15, 2004</rights><rights>Copyright © 2004 Cancer Research UK 2004 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-70db895874c6ff5f5db07c7f94361b6cc47a993b264a8af20dd259b8f873dbb3</citedby><cites>FETCH-LOGICAL-c455t-70db895874c6ff5f5db07c7f94361b6cc47a993b264a8af20dd259b8f873dbb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410051/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410051/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15477859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peters-Engl, C</creatorcontrib><creatorcontrib>Konstantiniuk, P</creatorcontrib><creatorcontrib>Tausch, C</creatorcontrib><creatorcontrib>Haid, A</creatorcontrib><creatorcontrib>Hoffmann, B</creatorcontrib><creatorcontrib>Jagoutz-Herzlinger, M</creatorcontrib><creatorcontrib>Kugler, F</creatorcontrib><creatorcontrib>Redtenbacher, S</creatorcontrib><creatorcontrib>Roka, S</creatorcontrib><creatorcontrib>Schrenk, P</creatorcontrib><creatorcontrib>Steinmassl, D</creatorcontrib><creatorcontrib>Austrian Sentinel Node Biopsy Study Group</creatorcontrib><title>The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><description>Preoperative breast biopsy might cause disaggregation of tumour cells and tumour cell spread. The purpose of this study was to investigate the impact of preoperative biopsy on the rate of metastases to the sentinel lymph node (SLN) of patients with primary breast cancer. We report the results of 2502 patients with primary breast cancer, who were operated, and a sentinel node biopsy was performed. The association of preoperative biopsy with the risk of SLN metastases was examined by regression analyses and tested for possible confounding well-known factors for axillary node metastases. In all, 1890 patients were available for final analyses; 1048 (55.4%) patients had a preoperative diagnosis performed by fine-needle aspiration or core biopsy; 641 (33.9%) patients had a positive SLN when conventional H&E and IHC staining was performed. Patients with preoperative breast biopsy showed a 1.37 times (95% CI, 1.13–1.66) increased risk of SLN metastases on univariate analysis, but this result was not persistent when analysis was adjusted for other relevant factors for axillary node metastases, OR 1.09 (95% CI, 0.85–1.40). In addition, subgroup analyses of the risk for occult micro metastases to the SLN (detected by IHC only) on H&E-negative cases also showed no increased risk associated with preoperative biopsy, OR 1.07 (95% CI, 0.69–1.65). The conclusion, based on the present data, is that preoperative breast biopsy does not cause artificial tumour cell spread to the SLN, with possible negative impact on the prognosis of breast cancer.</description><subject>Aged</subject><subject>Austria</subject><subject>Axilla</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biopsy</subject><subject>Biopsy, Needle</subject><subject>Breast Neoplasms - diagnosis</subject><subject>Breast Neoplasms - pathology</subject><subject>Cancer Research</subject><subject>Clinical</subject><subject>Disease Progression</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Middle Aged</subject><subject>Molecular Medicine</subject><subject>Oncology</subject><subject>Preoperative Care</subject><subject>Regression Analysis</subject><subject>Risk</subject><subject>Sentinel Lymph Node Biopsy</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kc-P1CAUx4nRuOPq1aMhHrx1llIoxYPJZuOvZBMvcydA6Qy1LZVHN5k_x_9UZqdx1MQTgfd5n_fCF6HXJdmWpGpuoN-a3m7rmlBK-BO0KXlFi7Kh4inaEEJEQSQlV-gFQJ-vkjTiOboqOROi4XKDfu4ODvtx1jbh0OE5ujC7qJN_cNhEpyFh48MMRxwmnDIbPXw_keCm5Cc34OE4zgc8hdbh0aXcoMHBe6wnPRzBw4mlnFBsT--4i2F89NwukKLX00X0qFiHQVraI97HsMwv0bNOD-Berec12n36uLv7Utx_-_z17va-sIzzVAjSmkbyRjBbdx3veGuIsKKTrKpLU1vLhJayMrRmutEdJW1LuTRN14iqNaa6Rh_O2nkxo2tt3irqQc3RjzoeVdBe_V2Z_EHtw4OirCSEl1nwbhXE8GNxkNTowbph0JMLC6hakJpVjGXw7T9gH5aYvwsUpVIKxkSToe0ZsjEARNf93qQk6pS8gl7l5NWafG548-f-F3yNOgM3ZwByadq7eBn7H-UvXV6-ZA</recordid><startdate>20041115</startdate><enddate>20041115</enddate><creator>Peters-Engl, C</creator><creator>Konstantiniuk, P</creator><creator>Tausch, C</creator><creator>Haid, A</creator><creator>Hoffmann, B</creator><creator>Jagoutz-Herzlinger, M</creator><creator>Kugler, F</creator><creator>Redtenbacher, S</creator><creator>Roka, S</creator><creator>Schrenk, P</creator><creator>Steinmassl, D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20041115</creationdate><title>The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group</title><author>Peters-Engl, C ; Konstantiniuk, P ; Tausch, C ; Haid, A ; Hoffmann, B ; Jagoutz-Herzlinger, M ; Kugler, F ; Redtenbacher, S ; Roka, S ; Schrenk, P ; Steinmassl, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-70db895874c6ff5f5db07c7f94361b6cc47a993b264a8af20dd259b8f873dbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Austria</topic><topic>Axilla</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biopsy</topic><topic>Biopsy, Needle</topic><topic>Breast Neoplasms - diagnosis</topic><topic>Breast Neoplasms - pathology</topic><topic>Cancer Research</topic><topic>Clinical</topic><topic>Disease Progression</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Middle Aged</topic><topic>Molecular Medicine</topic><topic>Oncology</topic><topic>Preoperative Care</topic><topic>Regression Analysis</topic><topic>Risk</topic><topic>Sentinel Lymph Node Biopsy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peters-Engl, C</creatorcontrib><creatorcontrib>Konstantiniuk, P</creatorcontrib><creatorcontrib>Tausch, C</creatorcontrib><creatorcontrib>Haid, A</creatorcontrib><creatorcontrib>Hoffmann, B</creatorcontrib><creatorcontrib>Jagoutz-Herzlinger, M</creatorcontrib><creatorcontrib>Kugler, F</creatorcontrib><creatorcontrib>Redtenbacher, S</creatorcontrib><creatorcontrib>Roka, S</creatorcontrib><creatorcontrib>Schrenk, P</creatorcontrib><creatorcontrib>Steinmassl, D</creatorcontrib><creatorcontrib>Austrian Sentinel Node Biopsy Study Group</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing & Allied Health Source</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peters-Engl, C</au><au>Konstantiniuk, P</au><au>Tausch, C</au><au>Haid, A</au><au>Hoffmann, B</au><au>Jagoutz-Herzlinger, M</au><au>Kugler, F</au><au>Redtenbacher, S</au><au>Roka, S</au><au>Schrenk, P</au><au>Steinmassl, D</au><aucorp>Austrian Sentinel Node Biopsy Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2004-11-15</date><risdate>2004</risdate><volume>91</volume><issue>10</issue><spage>1782</spage><epage>1786</epage><pages>1782-1786</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><abstract>Preoperative breast biopsy might cause disaggregation of tumour cells and tumour cell spread. The purpose of this study was to investigate the impact of preoperative biopsy on the rate of metastases to the sentinel lymph node (SLN) of patients with primary breast cancer. We report the results of 2502 patients with primary breast cancer, who were operated, and a sentinel node biopsy was performed. The association of preoperative biopsy with the risk of SLN metastases was examined by regression analyses and tested for possible confounding well-known factors for axillary node metastases. In all, 1890 patients were available for final analyses; 1048 (55.4%) patients had a preoperative diagnosis performed by fine-needle aspiration or core biopsy; 641 (33.9%) patients had a positive SLN when conventional H&E and IHC staining was performed. Patients with preoperative breast biopsy showed a 1.37 times (95% CI, 1.13–1.66) increased risk of SLN metastases on univariate analysis, but this result was not persistent when analysis was adjusted for other relevant factors for axillary node metastases, OR 1.09 (95% CI, 0.85–1.40). In addition, subgroup analyses of the risk for occult micro metastases to the SLN (detected by IHC only) on H&E-negative cases also showed no increased risk associated with preoperative biopsy, OR 1.07 (95% CI, 0.69–1.65). The conclusion, based on the present data, is that preoperative breast biopsy does not cause artificial tumour cell spread to the SLN, with possible negative impact on the prognosis of breast cancer.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>15477859</pmid><doi>10.1038/sj.bjc.6602205</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0920 |
| ispartof | British journal of cancer, 2004-11, Vol.91 (10), p.1782-1786 |
| issn | 0007-0920 1532-1827 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2410051 |
| source | MEDLINE; Nature; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings |
| subjects | Aged Austria Axilla Biomedical and Life Sciences Biomedicine Biopsy Biopsy, Needle Breast Neoplasms - diagnosis Breast Neoplasms - pathology Cancer Research Clinical Disease Progression Drug Resistance Epidemiology Female Humans Lymphatic Metastasis Middle Aged Molecular Medicine Oncology Preoperative Care Regression Analysis Risk Sentinel Lymph Node Biopsy |
| title | The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian sentinel node biopsy study group |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A35%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20impact%20of%20preoperative%20breast%20biopsy%20on%20the%20risk%20of%20sentinel%20lymph%20node%20metastases:%20analysis%20of%202502%20cases%20from%20the%20Austrian%20sentinel%20node%20biopsy%20study%20group&rft.jtitle=British%20journal%20of%20cancer&rft.au=Peters-Engl,%20C&rft.aucorp=Austrian%20Sentinel%20Node%20Biopsy%20Study%20Group&rft.date=2004-11-15&rft.volume=91&rft.issue=10&rft.spage=1782&rft.epage=1786&rft.pages=1782-1786&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6602205&rft_dat=%3Cproquest_pubme%3E67064344%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229974478&rft_id=info:pmid/15477859&rfr_iscdi=true |